Piper Sandler lowered the firm’s price target on Eastman Chemical (EMN) to $89 from $99 and keeps a Neutral rating on the shares. The firm is updating its Eastman model based on the release of Q1 results, updated company guidance for Q2 and FY25 and changes to its views regarding both the macroeconomic environment and industry environment, which have both taken significantly negative turns.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EMN:
- Eastman Chemical price target lowered to $85 from $108 at Barclays
- Promising Outlook for Eastman Chemical Amid Challenges: Buy Rating Supported by Strategic Initiatives and Strong Segment Performance
- Eastman Chemical price target lowered to $93 from $97 at BofA
- Eastman Chemical: Buy Rating Affirmed Amid Strong Financial Resilience and Attractive Risk/Reward Profile
- Eastman Chemical price target lowered to $115 from $125 at Morgan Stanley